9.49
0.21%
+0.02
Dopo l'orario di chiusura:
9.32
-0.17
-1.79%
Benitec Biopharma Inc Azioni (BNTC) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 |
Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
Revenues |
-
|
- | 0.007 | 0.054 | 0.014 |
Operating Expenses
|
17.93%
6.927
|
5.874 | 4.557 | 4.395 | 5.624 |
Operating Income/Loss |
17.93%
-6.927
|
-5.874 | -4.55 | -4.341 | -5.61 |
Nonoperating Income/Loss |
261.25%
0.129
|
-0.08 | -0.111 | -0.056 | 0.199 |
Income/Loss From Continuing Operations Before Tax |
14.18%
-6.798
|
-5.954 | 0.007 | 0.054 | -5.411 |
Income/Loss From Continuing Operations After Tax |
14.18%
-6.798
|
-5.954 | -4.661 | -4.397 | -5.411 |
Net Income/Loss
|
14.18%
-6.798
|
-5.954 | -4.661 | -4.397 | -5.411 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
19.44%
2.5763
|
2.1571 | -20.70 | 27.98 | 27.56 |
Diluted Average Shares |
19.44%
2.5763
|
2.1571 | -20.70 | 27.98 | 27.56 |
Basic Earnings Per Share |
4.35%
-2.64
|
-2.76 | -13.45 | -0.16 | -0.20 |
Diluted Earnings Per Share |
4.35%
-2.64
|
-2.76 | -13.45 | -0.16 | -0.20 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Capitalizzazione:
|
Volume (24 ore):